No article text was recorded for this version.
blood-brain barrier permeability (blood-brain barrier penetration)
Version 2 of 2207 papers245 conceptsfrozen 2026-10-04
Papers in this version
- Blog: EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
- Blog: A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain
- Blog: Response to furmonertinib in a patient with non-Small cell lung cancer harboring HER2 exon 21 insertion mutation : a case report
- Blog: Radiochemical Synthesis and Evaluation of 3-[ <sup>11</sup> C]Methyl-4-aminopyridine in Rodents and Non-Human Primates for Imaging Potassium Channels in the CNS
- Blog: Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
- Blog: Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara
- Blog: Phosphodiesterase 4 inhibition as a novel treatment for stroke
- Blog: Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells
- Blog: Celastrol alleviates comorbid obesity and depression by directly binding amygdala hnRNPA1 in a mouse model
- Blog: Integrated Mass Spectrometry Reveals Celastrol As a Novel Catechol-O-methyltransferase Inhibitor
- Blog: Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles
- Blog: Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
- Blog: A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques
- Blog: Electroacupuncture Potentiates Astragaloside IV Cerebral Delivery via P‐Glycoprotein‐Mediated Transcellular Transport: A Novel Blood–Brain Barrier Penetration Strategy for Ischemic Stroke Therapy
- Blog: In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
- Blog: Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma
- Blog: Wnt activation as a therapeutic strategy in medulloblastoma
- Blog: Structural and molecular basis of choline uptake into the brain by FLVCR2
- Blog: Memantine and q-vd-oph treatments in experimental spinal cord injury: combined inhibition of necrosis and apoptosis
- Blog: MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb
- Blog: Pharmacological activation of GPR55 improved cognitive impairment, neuroinflammation, oxidative stress and apoptosis induced by lipopolysaccharide in mice
- Blog: Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
- Blog: In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor
- Blog: Acute Encephalopathy Associated with Influenza A Infection in Adults
- Blog: Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin
- Blog: Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
- Blog: Vitexin induces G2/M‑phase arrest and apoptosis via Akt/mTOR signaling pathway in human glioblastoma cells
- Blog: Effect of the plant flavonoid, rhoifolin, on memory and cognition in a rat model of Alzheimer’s disease
- Blog: LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression
- Blog: Exploration and Exploitation Approaches Based on Generative Machine Learning to Identify Potent Small Molecule Inhibitors of α-Synuclein Secondary Nucleation
- Blog: Relational graph convolutional networks for predicting blood-brain barrier penetration of drug molecules
- Blog: Development of an RNA Aptamer as a Therapeutic Agent for Synucleinopathies
- Blog: Carbon Quantum Dots of Ginsenoside Rb1 for Application in a Mouse Model of Intracerebral Hemorrhage
- Blog: Autophagy Inhibition and Inflammation Activation Induced by Phosphorylated Alpha-synuclein Through Toll-like Receptor 2 Pathway in the Hippocampus of MPTP&nbsp;Mouse Model of Parkinson’s Disease Contribute to Its Cognitive Function Decline in the Early Stage
- Blog: Neuroprotection Against MPP+-Induced Cytotoxicity Through the Activation of PI3-K/Akt/GSK3β/MEF2D Signaling Pathway by Rhynchophylline, the Major Tetracyclic Oxindole Alkaloid Isolated From Uncaria rhynchophylla
- Blog: Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing
- Blog: Gardenia-derived extracellular vesicles exert therapeutic effects on dopaminergic neuron apoptosis-mediated Parkinson’s disease
- Blog: Brain-wide measurement of synaptic protein turnover reveals localized plasticity during learning
- Blog: In vivo labeling and quantitative imaging of neurons using MRI
- Blog: Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism
- Blog: Carbon Monoxide Nanomodulator Reverses Ischemia‐Reperfusion Injury in Stroke: A Novel Dual‐Channel Therapy Mode of Co‐driving Neuroprotection and Neurogenesis
- Blog: The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis
- Blog: Correlation of Metabolic Profiles of Plasma and Cerebrospinal Fluid of High-Grade Glioma Patients
- Blog: Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology
- Blog: Daphnetin protects oxidative stress-induced neuronal apoptosis via regulation of MAPK signaling and HSP70 expression
- Blog: Antibody targeting of aging damaged isoDGR-proteins doubles lifespan in a mouse model of chronic inflammation
- Blog: Curcumin-dependent phenotypic transformation of microglia mediates resistance to pseudorabies-induced encephalitis
- Blog: Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
- Blog: Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial
- Blog: Mitochondrion-based organellar therapies for central nervous system diseases
- Blog: Underestimated virus impaired cognition-more evidence and more work to do
- Blog: Hyper-Glycosylation as a Central Metabolic Driver of Alzheimer’s Disease
- Blog: Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia
- Blog: Mechanisms of Xiaoyao San in Treating Depression: A Comprehensive Review of Pharmacological Actions and Clinical Evidence
- Blog: Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib
- Blog: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease
- Blog: The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis
- Blog: Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
- Blog: Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
- Blog: Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Showing 60 of 207 papers.
History & citation
Current · Permanent link
- blood-brain barrier bypass split from this direction (59% overlap)
- blood-brain barrier permeability (physiological drug delivery barriers) split from this direction (100% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_blood_brain_barrier_permeability_blood_b_8fa986d0,
title = {blood-brain barrier permeability (blood-brain barrier penetration)},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/blood-brain-barrier-permeability-blood-brain-barrier-penetration/rdr_8fa986d04a2e44ddbfdb7ea2e1d275d8},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_blood_brain_barrier_permeability_blood_b_8fa986d0_v2,
title = {blood-brain barrier permeability (blood-brain barrier penetration)},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/blood-brain-barrier-permeability-blood-brain-barrier-penetration/rdr_8fa986d04a2e44ddbfdb7ea2e1d275d8/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}